Thalassemia natural history, complications and prognosis

Jump to navigation Jump to search

Thalassemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thalassemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Thalassemia natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Thalassemia natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thalassemia natural history, complications and prognosis

CDC on Thalassemia natural history, complications and prognosis

Thalassemia natural history, complications and prognosis in the news

Blogs on Thalassemia natural history, complications and prognosis

Directions to Hospitals Treating Thalassemia

Risk calculators and risk factors for Thalassemia natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Natural History

Complications

Untreated thalassemia Major eventually leads to death usually by heart failure, therefore birth screening is very important. β-Thalassemia cardiomyopathy takes on two phenotypes:

Dilated phenotype: Left ventricular dilatation and impaired contractility are present
Restrictive phenotype: Restrictive left ventricular filling is present along with pulmonary hypertension, and right heart failure.

The pathophysiology of β-Thalassemia cardiomyopathy is multifactorial, with myocardial iron overload and immunoinflammatory processes being the predominant mechanisms.

All Thalassemia patients are susceptible to health complications that involve the spleen (which is often enlarged and frequently removed) and gall stones. These complications are mostly prevalent to thalassemia Major and Intermedia patients.

Prognosis

References


Template:WH Template:WS